Rethink Criteria for Monitoring Psychedelics Trials, Commenters Tell FDA

The FDA’s draft guidance on psychedelic drug trials excludes many nurses from serving as lead and assistant monitors, according to sponsors, nurses and nonprofits amongst the more than 160 comments the agency received.
Source: Drug Industry Daily